RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Houston, TX · San Antonio, TX · +21 more sites
Breast Cancer clinical trials in San Antonio, TX
31 recruiting breast cancer studies with a site in San Antonio, TX.
RecruitingPhase 1NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Sponsor: BeOne Medicines
Houston, TX · Irving, TX · San Antonio, TX · +6 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · El Paso, TX · Houston, TX · +36 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Abilene, TX · Baytown, TX · Dallas, TX · +126 more sites
RecruitingPhase 1NCT06840886
A Study of PHST001 in Advanced Solid Tumors
Sponsor: Pheast Therapeutics
Fort Worth, TX · Houston, TX · Irving, TX · +17 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Austin, TX · Houston, TX · Irving, TX · +15 more sites
RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Abilene, TX · Allen, TX · Dallas, TX · +173 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Dallas, TX · Edinburg, TX · Forth Worth, TX · +30 more sites
RecruitingPhase 1 / Phase 2NCT06657222
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Sponsor: Gilead Sciences
Austin, TX · Irving, TX · San Antonio, TX · +10 more sites
RecruitingPhase 1NCT06440005
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Sponsor: Angiex, Inc.
Houston, TX · San Antonio, TX · +5 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Amarillo, TX · Angleton, TX · Baytown, TX · +1223 more sites
RecruitingPhase 3NCT06072612
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sponsor: BriaCell Therapeutics Corporation
Dallas, TX · Edinburg, TX · +76 more sites
RecruitingPhase 1NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Sponsor: Nammi Therapeutics Inc
San Antonio, TX · +9 more sites
RecruitingPhase 1NCT07182149
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Sponsor: Normunity AccelCo, Inc.
Dallas, TX · Houston, TX · San Antonio, TX · +15 more sites
RecruitingPhase 3NCT05232916
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Sponsor: Greenwich LifeSciences, Inc.
Austin, TX · Dallas, TX · +48 more sites
RecruitingPhase 1NCT06910657
IDOV-Immune for Advanced Solid Tumors
Sponsor: ViroMissile, Inc.
Houston, TX · San Antonio, TX · +1 more sites
RecruitingPhase 1NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Sponsor: MOMA Therapeutics
San Antonio, TX · +11 more sites
RecruitingPhase 1NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
Conroe, TX · Houston, TX · +10 more sites
RecruitingPhase 1NCT07524322
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Sponsor: Regor Pharmaceuticals Inc.
Houston, TX · San Antonio, TX · +2 more sites
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
Amarillo, TX · Dallas, TX · Houston, TX · +14 more sites
RecruitingPhase 1 / Phase 2NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Sponsor: Eli Lilly and Company
Dallas, TX · +25 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Houston, TX · +103 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Austin, TX · Dallas, TX · Fort Worth, TX · +8 more sites
RecruitingNot applicableNCT07574671
Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer
Sponsor: The University of Texas Health Science Center at San Antonio
San Antonio, TX
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Abilene, TX · Baytown, TX · Conroe, TX · +809 more sites
RecruitingPhase 1NCT07424547
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Austin, TX · San Antonio, TX · +3 more sites
RecruitingPhase 2NCT05748834
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Sponsor: SCRI Development Innovations, LLC
Dallas, TX · San Antonio, TX · +6 more sites
RecruitingPhase 1 / Phase 2NCT06956690
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Sponsor: Hummingbird Bioscience
Dallas, TX · San Antonio, TX · +3 more sites
RecruitingPhase 1NCT07190469
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
Sponsor: ProteinQure Inc.
Houston, TX · San Antonio, TX · +1 more sites
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Austin, TX · Dallas, TX · San Antonio, TX · +7 more sites
RecruitingPhase 1 / Phase 2NCT06827613
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
Sponsor: Marengo Therapeutics, Inc.
San Antonio, TX · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.